Search results
Added:
1 year ago
ESC HF 25 - Outcomes from a study investigating liver stiffness measurement as a non-invasive method to assess central venous pressure showed immediate results at bedside obtained in >4 minutes, with the procedure easily performed by a trained nurse.Prof Nicolas Girerd (University Hospital of Nancy, Nancy, FR) discusses a pilot validation study investigating liver stiffness as a non-invasive…
View more
Prathap Kanagala
Research Area(s) / Expertise:
Author
Added:
6 months ago
Source:
Radcliffe CVRM
A new pooled analysis suggests that measures of abdominal adiposity, such as waist-to-height ratio, are better predictors of clinical outcomes than body mass index (BMI) alone in patients with heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF). Obesity is highly prevalent in this patient population and is linked to an increased risk of mortality and disability.This…
View more
Added:
1 month ago
In this episode of Masterclass, host, Dr Harriette Van Spall speaks with Professor Faiez Zannad about the challenge of making heart failure evidence more globally representative.Professor Zannad is an emeritus Professor of Therapeutics and Cardiology at the University of Lorraine in Nancy, France, and a leading clinical trialist in heart failure whose studies have informed international treatment…
View more
Added:
7 months ago
Source:
Radcliffe Cardiology
Natriuretic peptides are key biomarkers used to risk-stratify patients with heart failure (HF), but current guideline thresholds do not typically account for body mass index (BMI).¹ A new pooled analysis suggests that these fixed thresholds may underestimate risk in patients with HF and higher BMI, questioning the one-size-fits-all approach.²This study was a participant-level pooled analysis of…
View more
Added:
6 months ago
Source:
Radcliffe CVRM
Worsening kidney function is a known prognostic factor in heart failure with reduced ejection fraction (HFrEF), but a new analysis suggests this decline accelerates up to a year before a major heart failure (HF) event. The study examined data from two clinical trials, EPHESUS and EMPHASIS-HF, and the real-world BARCELONA cohort.¹This post-hoc analysis assessed longitudinal changes in estimated…
View more
SGLT2 Inhibitors in Acute Heart Failure
Added:
3 months ago
Viewpoint
ESC 24: MRAs in HF
Added:
1 year ago
Video
Hyperkalaemia in Acute Heart Failure: An Asian Population Study
Added:
11 months ago
Original Research
Added:
1 year ago
ESC HF 25 - In a FINEARTS HF post-hoc analysis, the relative and absolute effects of finerenone relative to placebo did not significantly differ across kidney function.We are joined by Dr Safia Chatur (Mass General Cardiology, US) to discuss key findings from the FINEARTS-HF trial. This Phase 3 study evaluated the effect of finerenone versus placebo on cardiovascular death and total heart failure…
View more